SEC Form 4 · accession 0001638599-16-001156
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William S Marth
Officer — President and CEO · Director
Period of report
Jul 5, 2016
Accepted (ET)
Jul 7, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2016 | A | 1,312 | $11.42 | A | 525,455 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Albany Molecular Research, Inc. Third Amended 1998 Employee Stock Purchase Plan.